Hypoplastic left heart syndrome can be diagnosed through an ultrasound while the baby is in the womb, and surgery is needed ...

Aim: Infants with Hypoplastic Left Heart Syndrome(HLHS) may suffer inhibited growth. Some papershave shown it in congenital heart disease. Aim:to check if that is true in HLHS. We will also ...

Looking for reliable medications to treat 'Hypoplastic Left Heart Syndrome'? This page offers a detailed resource for the most up-to-date treatment options, including both generic and brand-name ...

Baby Nestor was saved as Chernobyl Children International had a cardiac surgical team in Ukraine working to saving the lives ...

The 71st Annual KDKA-TV Free Care Fund Telethon is this Thursday and all week, we're introducing you to some of the local ...

New York Gov. Andrew Cuomo signed the pulse ox bill into law, and it took effect in January 2014. Now, every baby born in New ...

Lavine Kory Lavine, MD, PhD, the Alan A. and Edith L. Wolff Professor of Cardiology and a professor of medicine at WashU ...

Roth MKM last night initiated coverage of Longeveron (LGVN) with a Buy rating and $10 price target The firm says its ...

designation following submission of results from the randomized controlled trial in children with hypoplastic left heart syndrome (HLHS), a potentially life threatening congenital heart condition.

reducing inflammation and preventing the immune system from attacking healthy tissues, creating a favourable environment for tissue growth ("immunomodulation").

FDA granted REVASCOR both Rare Pediatric Disease Designation (RPDD) and Orphan-Drug Designation (ODD) for congenital heart diseaseNEW YORK, Dec. 04, 2024 (GLOBE NEWSWIRE) -- (Nasdaq:MESO; ASX:MSB), ...